Garvey WT, Frias JP, Jastreboff AM et al (2023) Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Describing the impact of the study, Dr
Bottom Line: Which should I use Tirzepatide or Semaglutide
Qiqi Song, [email protected]
Compounded medications are not required to meet the same manufacturing standards, undergo the same large-scale testing, or demonstrate the same batch-to-batch consistency as FDA-approved drugs
Popular combinations include Botox and dermal fillers to maintain a youthful appearance as you lose weight, HydraFacial to support skin health and elasticity, and peptide therapy to preserve muscle mass and support recovery